Both OSM and IL-6 could stimulate the proliferation of prostate cancer 22Rv1 cells [178] and stimulate u-Plasminogen Activator and VEGF in DU-145 prostate cancer cells [179]. The gene discussed is IL6; the disease is prostate carcinoma.